Desfarges S, San Filippo J, Fournier M, Calmels C, Caumont-Sarcos A, Litvak S, Sung P, Parissi V
UMR 5097-CNRS, Bordeaux, France.
Nucleic Acids Res. 2006;34(21):6215-24. doi: 10.1093/nar/gkl843. Epub 2006 Nov 7.
HIV-1 integrase (IN) is the key enzyme catalyzing the proviral DNA integration step. Although the enzyme catalyzes the integration step accurately in vitro, whether IN is sufficient for in vivo integration and how it interacts with the cellular machinery remains unclear. We set up a yeast cellular integration system where integrase was expressed as the sole HIV-1 protein and targeted the chromosomes. In this simple eukaryotic model, integrase is necessary and sufficient for the insertion of a DNA containing viral LTRs into the genome, thereby allowing the study of the isolated integration step independently of other viral mechanisms. Furthermore, the yeast system was used to identify cellular mechanisms involved in the integration step and allowed us to show the role of homologous recombination systems. We demonstrated physical interactions between HIV-1 IN and RAD51 protein and showed that HIV-1 integrase activity could be inhibited both in the cell and in vitro by RAD51 protein. Our data allowed the identification of RAD51 as a novel in vitro IN cofactor able to down regulate the activity of this retroviral enzyme, thereby acting as a potential cellular restriction factor to HIV infection.
HIV-1整合酶(IN)是催化前病毒DNA整合步骤的关键酶。尽管该酶在体外能准确催化整合步骤,但IN对于体内整合是否足够以及它如何与细胞机制相互作用仍不清楚。我们建立了一个酵母细胞整合系统,其中整合酶作为唯一的HIV-1蛋白表达并靶向染色体。在这个简单的真核模型中,整合酶对于将含有病毒长末端重复序列(LTRs)的DNA插入基因组是必要且充分的,从而能够独立于其他病毒机制研究分离的整合步骤。此外,酵母系统被用于鉴定参与整合步骤的细胞机制,并使我们能够展示同源重组系统的作用。我们证明了HIV-1 IN与RAD51蛋白之间存在物理相互作用,并表明RAD51蛋白在细胞内和体外均可抑制HIV-1整合酶活性。我们的数据使得RAD51被鉴定为一种新型的体外IN辅因子,能够下调这种逆转录病毒酶的活性,从而作为对HIV感染的潜在细胞限制因子发挥作用。